Correction: J Exp Clin Cancer Res 35, 99 (2016)
https://doi.org/10.1186/s13046-016-0372-5
Following publication of the original article [1], author found errors in Fig. 7, specifically:
-
Fig. 7d – the result of flow cytometry assay in Tet-shRNA + Dox group was misplaced
-
Fig. 7f – the results of flow cytometry assay in Tet-shRNA –Dox group and Tet-NC–Dox group were misplaced
Transfection with si-HOXD-AS1 or tet shRNA induced apoptosis in 5637 and T24. a-c The rate of early apoptotic 5637 (P = 0.001) and T24 cells (P < 0.001) were increased significantly after transfection with si-HOXD-AS1. d-g Increased apoptotic cells were observed in tet-shRNA-transfected 5637 (P = 0.001) and T24 cells (P < 0.001). Results represent the mean ± SD from three independent experiments
The corrected Fig. 7 is given here. The correction does not affect the conclusions of the article.
Reference
Li J, Zhuang C, Liu Y, et al. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer. J Exp Clin Cancer Res. 2016;35:99. https://doi.org/10.1186/s13046-016-0372-5.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Li, J., Zhuang, C., Liu, Y. et al. Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer. J Exp Clin Cancer Res 42, 321 (2023). https://doi.org/10.1186/s13046-023-02908-6
Published:
DOI: https://doi.org/10.1186/s13046-023-02908-6